| FAT1 altered in cohorts of …ALTERED_INderived22 of 22show fewer |
|---|
| → altered in cohorts of | Skin Squamous Cell Carcinoma 25 / 83 cases (30 %) · ssm · cscc_ucsf_2021 | — | — | Skin Squamous Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Head and Neck Carcinoma, Other 25 / 108 cases (23 %) · ssm · ohnca_cptac_gdc | — | — | Head and Neck Carcinoma, Other | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Head and Neck Squamous Cell Carcinoma 111 / 515 cases (22 %) · ssm · hnsc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| → altered in cohorts of | Endometrial Carcinoma 103 / 517 cases (20 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 6 cohorts | — | — | Endometrial Carcinoma | 6 | Observed | cbioportal | graph → |
| → altered in cohorts of | Cutaneous Melanoma 136 / 696 cases (20 %) · ssm · mel_mskimpact_2020 | — | — | Cutaneous Melanoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Invasive Breast Carcinoma 89 / 527 cases (17 %) · ssm · brca_msk_2025 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Renal Cell Carcinoma 24 / 158 cases (15 %) · ssm · rcc_iatlas_immotion150_2018 | — | — | Renal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Lung Squamous Cell Carcinoma 68 / 484 cases (14 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| → altered in cohorts of | Lung Non-Small Cell Carcinoma 142 / 1,144 cases (12 %) · ssm · nsclc_tcga_broad_2016 · largest of 5 cohorts | — | — | Lung Non-Small Cell Carcinoma | 5 | Observed | cbioportal | graph → |
| → altered in cohorts of | Bladder Urothelial Carcinoma 58 / 474 cases (12 %) · ssm · blca_msk_tcga_2020 · largest of 6 cohorts | — | — | Bladder Urothelial Carcinoma | 6 | Observed | cbioportal | graph → |
| → altered in cohorts of | Endometrial Endometrioid Adenocarcinoma 29 / 247 cases (12 %) · ssm · uec_cptac_gdc | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Colon Adenocarcinoma 43 / 429 cases (10 %) · ssm · coad_tcga_gdc · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | B-Cell Non-Hodgkin Lymphoma 65 / 755 cases (8.6 %) · ssm · mbn_mdacc_2013 · largest of 3 cohorts | — | — | B-Cell Non-Hodgkin Lymphoma | 3 | Observed | cbioportal | graph → |
| → altered in cohorts of | Gastric Adenocarcinoma 37 / 436 cases (8.5 %) · ssm · stad_tcga_pan_can_atlas_2018 · largest of 3 cohorts | — | — | Gastric Adenocarcinoma | 3 | Observed | cbioportal | graph → |
| → altered in cohorts of | Lung Adenocarcinoma 222 / 2,653 cases (8.4 %) · ssm · luad_mskcc_2023_met_organotropism · largest of 10 cohorts | — | — | Lung Adenocarcinoma | 10 | Observed | cbioportal | graph → |
| → altered in cohorts of | Gastroesophageal Junction Adenocarcinoma 41 / 518 cases (7.9 %) · ssm · stes_tcga_pub | — | — | Gastroesophageal Junction Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Cervical Squamous Cell Carcinoma 23 / 291 cases (7.9 %) · ssm · cesc_tcga_pan_can_atlas_2018 · largest of 2 cohorts | — | — | Cervical Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | Rectal Adenocarcinoma 550 / 7,237 cases (7.6 %) · ssm · crc_msk_2026 | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Colorectal Adenocarcinoma 78 / 1,134 cases (6.9 %) · ssm · crc_msk_2017 · largest of 4 cohorts | — | — | Colorectal Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| → altered in cohorts of | Multiple Myeloma 54 / 961 cases (5.6 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| → altered in cohorts of | Diffuse Glioma 48 / 882 cases (5.4 %) · ssm · glioma_mskcc_2019 · largest of 3 cohorts | — | — | Diffuse Glioma | 3 | Observed | cbioportal | graph → |
| → altered in cohorts of | Adenoid Cystic Carcinoma 57 / 1,049 cases (5.4 %) · ssm · acc_2019 | — | — | Adenoid Cystic Carcinoma | 1 | Observed | cbioportal | graph → |